Skin Solutions

In 2026, hyperpigmentation in sensitive skin is increasingly viewed as a system problem involving pigment, inflammation, vascular changes, and barrier dysfunction, rather than excess melanin alone. Clinical data suggest 30–55%...

By 2026, persistent dark spots are increasingly viewed as a multi-factor skin condition involving pigment production, vascular dysfunction, and impaired barrier recovery rather than excess melanin alone. Clinical and OEM...

Uneven skin tone in 2026 is understood as the interaction of three factors: pigmentation, vascular redness, and skin barrier quality. Clinical data shows that visible tone irregularity is often caused...

Acne and post-acne marks are biologically different conditions that require different treatment strategies. Active acne is driven by inflammation, bacteria, excess sebum, and clogged follicles, while post-acne marks involve pigmentation...

Modern hyperpigmentation is increasingly viewed as a multi-layer process involving inflammation, pigment transfer, and skin barrier integrity rather than excess melanin alone. Ingredients such as Tranexamic Acid, Niacinamide, Vitamin C...

By 2026, Tranexamic Acid (TXA) and Niacinamide are viewed as complementary rather than competing ingredients for hyperpigmentation. TXA primarily reduces inflammation-related pigment signalling, while Niacinamide regulates melanosome transfer and strengthens...